CDx Diagnostics Overview
- Year Founded
-
1997
- Status
-
Private
- Employees
-
135
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
4
CDx Diagnostics General Information
Description
Developer of diagnostic systems designed to prevent cancer by detecting pre-cancerous cells. The company offers an accurate and non-invasive biopsy to evaluate common oral lesions to rule out dysplasia or cancer and prevent cancer of the oral cavity, pharynx, larynx, and esophagus through early detection of their easily treatable, pre-cancerous precursors, enabling doctors to enhance the detection of precancerous and cancerous tissue.
Contact Information
Website
www.cdxdiagnostics.comCorporate Office
- Four Executive Boulevard
- Suffern, NY 10901-4164
- United States
Corporate Office
- Four Executive Boulevard
- Suffern, NY 10901-4164
- United States
CDx Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CDx Diagnostics Comparisons
Industry
Financing
Details
CDx Diagnostics Competitors (4)
One of CDx Diagnostics’s 4 competitors is Freenome, a Formerly VC-backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Freenome | Formerly VC-backed | Brisbane, CA | ||||
| SAGA Diagnostics | Formerly VC-backed | Morrisville, NC | ||||
| Ibex Medical Analytics | Venture Capital-Backed | Tel Aviv, Israel | ||||
| Delfi Diagnostics | Venture Capital-Backed | Palo Alto, CA |
CDx Diagnostics Patents
CDx Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9068975-B1 | Computerized detection of laryngopharyngeal reflux | Active | 17-Jun-2010 | ||
| CA-2708211-A1 | Feature dependent extended depth of focusing on semi-transparent biological specimens | Active | 17-Aug-2007 | ||
| CA-2708211-C | Feature dependent extended depth of focusing on semi-transparent biological specimens | Active | 17-Aug-2007 | ||
| US-20020165467-A1 | Retractable brush for use with endoscope for brush biopsy | Active | 04-May-2001 | ||
| US-6494845-B2 | Retractable brush for use with endoscope for brush biopsy | Inactive | 04-May-2001 | A61B10/04 |
CDx Diagnostics Signals
CDx Diagnostics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CDx Diagnostics FAQs
-
When was CDx Diagnostics founded?
CDx Diagnostics was founded in 1997.
-
Where is CDx Diagnostics headquartered?
CDx Diagnostics is headquartered in Suffern, NY.
-
What is the size of CDx Diagnostics?
CDx Diagnostics has 135 total employees.
-
What industry is CDx Diagnostics in?
CDx Diagnostics’s primary industry is Decision/Risk Analysis.
-
Is CDx Diagnostics a private or public company?
CDx Diagnostics is a Private company.
-
What is CDx Diagnostics’s current revenue?
The current revenue for CDx Diagnostics is .
-
How much funding has CDx Diagnostics raised over time?
CDx Diagnostics has raised $16M.
-
Who are CDx Diagnostics’s investors?
Bhansali Equities, Ducera Growth Ventures, and Galen Partners have invested in CDx Diagnostics.
-
Who are CDx Diagnostics’s competitors?
Freenome, SAGA Diagnostics, Ibex Medical Analytics, and Delfi Diagnostics are competitors of CDx Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process